as expected, sofosbuvir was approved by the FDA. the language in the press release showed some wiggle room for geno 1. also gilead has set up an assistance program to make it accesible for all. there is language about
tx experienced, interferon intolerant, and advanced fibrosis patients getting acess to sofo/riba only. get back to you with link to press release
barry